Cognizant Technology Solutions Corporation Q4 FY2025 earnings call

Management Statement and Operational Highlights:

• Q4 Momentum: Revenue grew 3.8% year over year in constant currency, all organic, driven by North America. Financial services led growth with 9% Y/Y Q4 constant currency revenue and 7% for the year. Q4 bookings grew 9% Y/Y, with a record quarterly total contract value; signed 12 large deals with TCV >$100M, including one >$1B.
• Margins and AI: Adjusted operating margin was 16%, improved 30 basis points year over year. Over 4,000 AI engagements; >30% of developer effort in software development cycles is AI-assisted. 2025 revenues up 6.4% in constant currency, surpassing $20B; adjusted operating margin 15.8%, exceeding guidance.
• AI Strategy: Proprietary frameworks like Basis and context engineering; AI partnership ecosystem with NVIDIA, Anthropic, etc.; formed three units to industrialize AI builder stack. Talent strategy: Over 340,000 associates completed AI skilling; shifting to asynchronous autonomous software engineering model.
• Client Examples: Financial services incremental billion-dollar partnership, Cisco transforming customer interactions, healthcare sector automation (e.g., reduced enrollment cycle times from days to minutes).

Segment Performance:

• Financial Services: Led growth with full-year constant currency revenue growth of approximately 7%, driven by strong performance in North America across banking, financial services, and insurance clients. Saw steady improvement in discretionary spending and consistent large deal signings.
• Health Sciences: Resilient despite industry cost pressures, helping customers reduce costs while improving patient experiences and accelerating productivity. GenAI projects growing in areas like claims efficiency, clinical documentation, and customer experience. TriZetto remained a core differentiator.
• Products and Resources: Stable, though tariff uncertainty suppressed discretionary spending; expected large deal traction in 2026 to drive better performance.
• Communications, Media, and Technology: Fourth-quarter year-over-year growth among technology customers offset by weakness in comms and media. Tech clients rapidly innovating and adopting GenAI drove demand, while comms and media were impacted by end-market softness.
• Geographically: North America grew >4% in Q4 (driven by financial services and healthcare), Europe 2% (healthy growth in financial services and life sciences), Rest of the world in line with total company (Middle East drive).

Guidance:

• 2026 Q1: Revenue growth 2.7%-4.2% year over year in constant currency, including ~100 basis points from Three Cloud acquisition.
• 2026 Full-year: Revenue growth 4%-6.5% in constant currency, including ~150 basis points inorganic contribution (one-third from M&A). Adjusted operating margin 15.9%-16.1%, expansion driven by cost discipline and SG&A leverage. Free cash flow conversion 90-100% of net income. Adjusted diluted EPS guidance $5.56-$5.70, 5%-8% year-over-year growth. Expected to return ~$1.6B to shareholders. Evaluating primary offering and secondary listing in India.

Risks:

• Macro economic complexity and technological change could impact business.
• Uncertainty in regulatory pressures in health sciences segment.
• Labor law changes in India could impact costs.
• Dependence on large deals and their timely ramp-up.
• Risk associated with fixed price/success-based contracts and achieving cost curves.

Q: Jason Kupferberg asked about the AI topic, including package implementation percentage.

A: Ravi Kumar discussed context engineering and AI's role in reinventing processes, stating AI provides a new addressable spend and requires reinventing processes to harness its value.

Q: Jason Kupferberg inquired about gross margins.

A: Jatin Dalal explained that Q4 gross margin impact was due to higher bonus funding and salary increases, but noted productivity levers and continued focus on cost discipline.

Q: Tien-Tsin Huang questioned about large deal activity and pipeline.

A: Ravi Kumar and Jatin Dalal discussed strong bookings, pipeline strength, and sequential growth expectations for 2026, citing large deals and seasonality factors.

Q: Keith Bachman asked about fixed price contracts and BPO durability.

A: Jatin Dalal and Ravi Kumar talked about risk sharing in fixed price contracts and BPO as a long-term tailwind due to large addressable spend and need for process reinvention.

Q: Jim Schneider asked about Health Sciences growth and gross margin inflection.

A: Ravi Kumar and Jatin Dalal discussed Health Sciences growth driven by transformation opportunities and margin plans focusing on productivity and talent strategies.

Q: Bryan Bergin inquired about bookings to growth and SG&A.

A: Jatin Dalal addressed ACV softness due to deal bundling and emphasized SG&A focus as a continued area of optimization.

Q: James Faucette asked about near-term activity and India listing.

A: Ravi Kumar and Jatin Dalal talked about near-term activity driven by large deals and financial services, and progress on India listing with ongoing discussions with regulators.

Q: Rod Bourgeois asked about Claude plugins and workflow automation.

A: Ravi Kumar discussed AI partnerships and new addressable spend, highlighting AI's role in creating net new opportunities through process reinvention and contextual engineering.